SERPINH1 and gastric cancer: The results showed that GC patients with high SERPINH1 mRNA levels were associated with poorer OS (HR=1.56, 95%CI=1.31-1.85, P<0.0001, Figure 4C) and PFS (HR=1.73, 95%CI=1.41-2.12, P<0.0001, Figure 4D) than the GC patients with low SERPINH1 expression.